Top Markets
#1 Wibx Wibx +8.04%
#2 Status Status +7.32%
#3 Decred Decred +5.88%
#4 aelf aelf +5.13%
#5 Humanity Humanity +4.81%
#6 MarsCoin MarsCoin +3.34%
#7 TRIA TRIA +3.25%
#8 Rei Rei +2.83%
#9 Bless Bless +2.73%
#10 rsERG rsERG +2.41%
Coin of the day
Wibx Wibx
Settings
Language
ENGLISH
Currency
USD
Theme
Finch Therapeutics Group, Inc. Finch Therapeutics Group, Inc.

Finch Therapeutics Group, Inc.

FNCH
Rank in Stocks #30543
Finch Therapeutics is a microbiome technology company with a portfolio of... Finch Therapeutics is a microbiome technology company with a portfolio of intellectual property and microbiome assets. The company is now focused on realizing the value of its intellectual property estate and other assets, while supporting the advancement of its microbiome technology through partnerships and collaborations after winding down development efforts.
Share Price
$10.20
Last synced: 2026-08-05
Market Cap
$16.38M
Change (1 day)
2.00%
Change (1 year)
-18.40%
Country
US
Trade Finch Therapeutics Group, Inc. (FNCH)

Category

Healthcare
Earnings for Finch Therapeutics Group, Inc. (FNCH)
Earnings in 2026 TTM: 0
According to Finch Therapeutics Group, Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Finch Therapeutics Group, Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE